Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.

Noh Y, Seo SW, Jeon S, Lee JM, Kim JH, Kim GH, Cho H, Yoon CW, Kim HJ, Ye BS, Kim ST, Choe YS, Lee KH, Kim JS, Ewers M, Weiner MW, Lee JH, Werring DJ, Kang DR, Kim CS, Na DL.

J Alzheimers Dis. 2014;40(4):877-86. doi: 10.3233/JAD-130461.

PMID:
24577457
[PubMed - indexed for MEDLINE]
2.

Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.

Kim HJ, Ye BS, Yoon CW, Cho H, Noh Y, Kim GH, Choi YS, Kim JH, Jeon S, Lee JM, Kim JS, Choe YS, Lee KH, Kim ST, Kim C, Kang DR, Ki CS, Lee JH, Werring DJ, Weiner MW, Na DL, Seo SW.

Neurobiol Aging. 2013 Nov;34(11):2482-7. doi: 10.1016/j.neurobiolaging.2013.05.009. Epub 2013 Jun 12.

PMID:
23769398
[PubMed - indexed for MEDLINE]
3.

Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment.

Park JH, Seo SW, Kim C, Kim SH, Kim GH, Kim ST, Jeon S, Lee JM, Oh SJ, Kim JS, Choe YS, Lee KH, Shin JS, Kim CH, Noh Y, Cho H, Yoon CW, Kim HJ, Ye BS, Ewers M, Weiner MW, Lee JH, Werring DJ, Na DL.

Neurobiol Aging. 2014 Jan;35(1):254-60. doi: 10.1016/j.neurobiolaging.2013.06.026. Epub 2013 Aug 7.

PMID:
23932881
[PubMed - indexed for MEDLINE]
4.

Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, Vashkevich A, Ayres AM, Auriel E, van Etten E, Becker A, Carmasin J, Schwab K, Rosand J, Johnson KA, Greenberg SM.

Ann Neurol. 2013 Apr;73(4):529-36. doi: 10.1002/ana.23830. Epub 2013 Feb 19.

PMID:
23424091
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.

Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):266-73. doi: 10.1136/jnnp-2013-305858. Epub 2013 Aug 21.

PMID:
23965289
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

White matter hyperintensities predict amyloid increase in Alzheimer's disease.

Grimmer T, Faust M, Auer F, Alexopoulos P, Förstl H, Henriksen G, Perneczky R, Sorg C, Yousefi BH, Drzezga A, Kurz A.

Neurobiol Aging. 2012 Dec;33(12):2766-73. doi: 10.1016/j.neurobiolaging.2012.01.016. Epub 2012 Mar 10.

PMID:
22410648
[PubMed - indexed for MEDLINE]
7.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

PMID:
22628162
[PubMed - indexed for MEDLINE]
Free Article
8.

Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI.

Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust WJ, Sanossian N, Mack WJ, Chui HC, Weiner MW.

PLoS One. 2013 Jun 6;8(6):e65175. doi: 10.1371/journal.pone.0065175. Print 2013.

PMID:
23762308
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Blood viscosity in subcortical vascular mild cognitive impairment with versus without cerebral amyloid burden.

Noh HJ, Seo SW, Jeong Y, Park JE, Kim GH, Noh Y, Cho H, Kim HJ, Yoon CW, Ye BS, Werring DJ, Na DL.

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):958-66. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.004. Epub 2014 Feb 28.

PMID:
24589034
[PubMed - indexed for MEDLINE]
10.

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.

Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ.

Alzheimers Dement. 2013 Nov;9(6):687-698.e1. doi: 10.1016/j.jalz.2012.10.012. Epub 2013 Mar 7.

PMID:
23474040
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment.

Lee MJ, Seo SW, Na DL, Kim C, Park JH, Kim GH, Kim CH, Noh Y, Cho H, Kim HJ, Yoon CW, Ye BS, Chin J, Jeon S, Lee JM, Choe YS, Lee KH, Kim JS, Kim ST, Lee JH, Ewers M, Werring DJ, Weiner MW.

JAMA Psychiatry. 2014 Apr;71(4):412-22. doi: 10.1001/jamapsychiatry.2013.4506.

PMID:
24554306
[PubMed - indexed for MEDLINE]
12.

Amyloid deposition in early onset versus late onset Alzheimer's disease.

Cho H, Seo SW, Kim JH, Suh MK, Lee JH, Choe YS, Lee KH, Kim JS, Kim GH, Noh Y, Ye BS, Kim HJ, Yoon CW, Chin J, Na DL.

J Alzheimers Dis. 2013;35(4):813-21. doi: 10.3233/JAD-121927.

PMID:
23507771
[PubMed - indexed for MEDLINE]
13.

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.

Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9.

PMID:
21310725
[PubMed - indexed for MEDLINE]
Free Article
14.

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

Raji CA, Becker JT, Tsopelas ND, Price JC, Mathis CA, Saxton JA, Lopresti BJ, Hoge JA, Ziolko SK, DeKosky ST, Klunk WE.

J Neurosci Methods. 2008 Jul 30;172(2):277-82. doi: 10.1016/j.jneumeth.2008.05.005. Epub 2008 May 16.

PMID:
18582948
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Fibrillar amyloid correlates of preclinical cognitive decline.

Stonnington CM, Chen K, Lee W, Locke DE, Dueck AC, Liu X, Roontiva A, Fleisher AS, Caselli RJ, Reiman EM.

Alzheimers Dement. 2014 Jan;10(1):e1-8. doi: 10.1016/j.jalz.2013.01.009. Epub 2013 Apr 11.

PMID:
23583233
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, Mathis CA.

Arch Neurol. 2009 Jan;66(1):60-7. doi: 10.1001/archneurol.2008.511.

PMID:
19139300
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.

Nebes RD, Snitz BE, Cohen AD, Aizenstein HJ, Saxton JA, Halligan EM, Mathis CA, Price JC, Kamboh MI, Weissfeld LA, Klunk WE.

Neuropsychologia. 2013 Sep;51(11):2202-9. doi: 10.1016/j.neuropsychologia.2013.07.017. Epub 2013 Aug 1.

PMID:
23911776
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.

Brain. 2008 Mar;131(Pt 3):665-80. doi: 10.1093/brain/awm336. Epub 2008 Feb 7.

PMID:
18263627
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

PMID:
19339253
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Guzman VA, Meier IB, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative.

JAMA Neurol. 2013 Apr;70(4):455-61. doi: 10.1001/jamaneurol.2013.1321.

PMID:
23420027
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk